Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari

About this update from Quantum Biopharma Ltd. Subordinate Voting Shares Class B

[{"type":"text","content":"Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza BokhariDr. Raza Bokhari, Company’s Former CEO, Paid $2.35 Million USD in Non-Dilutive Cash to Cover Legal and Other Costs Determined in the Arbitral Award Over the Past 4 Years\n\n\n\n TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“\n \n Quantum BioPharma\n \n ” or the “\n \n Company\n \n ”), announced today that the Company and Dr. Raza Bokhari, Company’s former Executive Chairman and Chief Executive Officer (CEO), have reached a global settlement agreement (the “\n \n agreement\n \n ”) to settle all and any disputes originating out of the proxy contest originally commencing January 2021. Mr. Zeeshan Saeed, Co-Chairman & CEO, and Mr. Anthony Durkacz, Co-Chairman of the Company, also signed the agreement in their personal capacity.\n \n\n The agreement brings to a complete and final closure all outstanding issues and prevents any future litigation in various courts in Canada and the United States. The payment of $2,350,000 USD from Dr. Bokhari to Quantum BioPharma Ltd. (Formerly FSD Pharma Inc.) satisfies all outstanding monetary claims by the Company, Zeeshan Saeed, Anthony Durkacz and other current or former employees, officers, Directors, affiliates or agents of the Company as well as any and all legal and monetary claims by Dr. Bokhari. The $2,350,000 USD is a non-dilutive injection of cash into Quantum BioPharma.\n \n\n In the agreement, Dr. Raza Bokhari, Quantum BioPharma Ltd, Zeeshan Saeed and Anthony Durkacz did not admit to any wrongdoing. All parties agreed that at all times they were acting in the best interest of the corporation and the shareholders.\n \n\n The various legal disputes between the parties will be entirely settled and certain disputes are summarized below:\n \n\n\n FSD Pharma Inc. v. Bokhari, Nos. 24-2281 and 24-2282 (3d Cir.)\n \n\n\n U.S. Court of Appeals for the Third Circuit, appealing the orders confirming the Awards and entering Judgment. The District Court confirmed the Awards by a Memorandum and Order dated May 29, 2024. Then, on June 27, 2024, the District Court entered Judgment in FSD’s favor, as follows:\n \n\n\n $147,301.04 (USD) plus interest at a rate of 4% per ...

More updates from Quantum Biopharma Ltd. Subordinate Voting Shares Class B